Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries

Archives of Cardiovascular Diseases
Sylvie LangAriel Cohen

Abstract

The widespread use of combination antiretroviral therapy (cART) among people living with HIV in developed countries has lead to significantly improved life expectancy. However, extensive use of the effective cART coincides with increasing reports of coronary heart disease (CHD) among people living with HIV, and CHD has become a major cause of death. CHD results from a complex and multifactorial atherosclerotic process involving the over-representation of traditional cardiovascular risk factors, particularly smoking, uncontrolled viral replication, chronic inflammation, immune activation, and exposure to antiretroviral drugs. Consequently careful selection of antiretroviral drugs, cardiovascular risk reduction, and lifestyle modifications are needed. In individuals living with HIV, cardiovascular risk assessment is becoming an important element of care.

References

Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Max H DavidCarl J Fichtenbaum
Aug 3, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel KleinStephen Sidney
Dec 14, 2002·Lancet·Scott D HolmbergUNKNOWN HIV Outpatient Study (HOPS) investigators
Feb 18, 2003·Archives of Internal Medicine·Shlomo MatetzkyBojan Cercek
Feb 21, 2003·The New England Journal of Medicine·Samuel A BozzetteThomas A Louis
Mar 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen HadiganSteven Grinspoon
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marianne SavèsUNKNOWN French WHO MONICA Project and the APROCO (ANRS EP11) Study Group
Oct 10, 2003·Advances in Cardiology·Daniel VittecoqGilles Chironi
Nov 25, 2003·The New England Journal of Medicine·Nina Friis-MøllerUNKNOWN Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
Aug 19, 2004·AIDS·A d'ArminioUNKNOWN Writing Committee of the D:A:D: Study Group
Aug 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B M BergersenS Tonstad
Jun 20, 2006·American Heart Journal·Isabella SudanoThomas F Lüscher
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Dec 1, 2006·The New England Journal of Medicine·UNKNOWN Strategies for Management of Antiretroviral Therapy (SMART) Study GroupC Rappoport
Apr 26, 2007·The Journal of Clinical Endocrinology and Metabolism·Virginia A TriantSteven K Grinspoon
Apr 27, 2007·The New England Journal of Medicine·UNKNOWN DAD Study GroupJens D Lundgren
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Niels ObelJan Gerstoft
Sep 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C KaplanStephen J Gange
Dec 3, 2009·Journal of Leukocyte Biology·Suzanne M CroweMichael Bukrinsky
Apr 13, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Antiretroviral Therapy Cohort Collaboration
Apr 20, 2010·AIDS·Sylvie LangUNKNOWN French Hospital Database on HIV-ANRS CO4
Aug 12, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amanda MocroftUNKNOWN EuroSIDA Study Group
Oct 23, 2010·European Heart Journal·Franck BoccaraUNKNOWN Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators
Jan 10, 2012·The Journal of Infectious Diseases·S W WormJ D Lundgren
May 19, 2012·Journal of the American College of Cardiology·Zian H TsengPriscilla Y Hsue
Sep 25, 2012·HIV Medicine·R WeberUNKNOWN Swiss HIV Cohort Study (SHCS)
Mar 6, 2013·JAMA Internal Medicine·Matthew S FreibergAmy C Justice
Jan 21, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael J SilverbergDaniel B Klein
Jun 6, 2014·AIDS·Philippe MorlatUNKNOWN ANRS EN20 Mortalité 2010 Study Group

❮ Previous
Next ❯

Citations

Jul 30, 2016·The Lancet. HIV·Luchuo Engelbert BainTarkang Elvis Enowbeyang
Dec 3, 2016·AIDS·Daniel WestreichAdaora A Adimora
Dec 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antoine MoulignierUNKNOWN Microvascular Brain Retina and Kidney (MicroBREAK) Study Group
Mar 8, 2017·Current Atherosclerosis Reports·John Charles A LacsonHossein Bahrami
Apr 2, 2017·Journal of the International AIDS Society·Cristin Q FritzC William Wester
Apr 20, 2018·Clinical Cardiology·Gbolahan O OgunbayoAdrian W Messerli
Aug 21, 2020·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Pratik MondalDiwakar Jain
May 5, 2018·European Heart Journal·Gary S Ma, Bruno R Cotter
Aug 3, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Saraschandra VallabhajosyulaGregory W Barsness
Dec 10, 2020·Ciência & saúde coletiva·Erika Aparecida Silveira, Marianne Oliveira Falco
Feb 25, 2021·Trends in Cardiovascular Medicine·Keir McCutcheonJohan Bennett
Dec 23, 2017·The American Journal of Emergency Medicine·Adrianna LongAlex Koyfman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.